General
Preferred name
FENSPIRIDE
Synonyms
FENSPIRIDE HYDROCHLORIDE ()
1-Oxa-3,8-diazaspiro(4.5)decan-2-one, 8-(2-phenylethyl)- ()
Fenspiride HCl ()
Pneumorel ()
Fluiden ()
Decaspiride ()
Fenspiride (Hydrochloride) ()
NDR-5998A ()
NSC-757825 ()
NAT-333 ()
Eurespal ()
Fenspirida ()
Fenspiride-d5 ()
P&D ID
PD009425
CAS
5053-08-7
5053-06-5
1246911-67-0
Tags
available
drug candidate
drug
Drug Status
approved
withdrawn
experimental
Max Phase
4.0
Drug indication
Airway obstruction
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Fenspiride, an orally active non-steroidal antiinflammatory agent, is an antagonist of H1-histamine receptor. Fenspiride inhibites phosphodiesterase 3 (PDE3), phosphodiesterase 4 (PDE4) and phosphodiesterase 5 (PDE5) activities with -log IC50 values of 3.44, 4.16 and approximately 3.8, respectively. Fenspiride can be used for the research of respiratory diseases[1][2][3].
PRICE
29
DESCRIPTION
alpha-Adrenoceptor antagonist; NSAID
(LOPAC library)
DESCRIPTION
Fenspiride hydrochloride (Decaspiride) , an oxazolidinone spiro compound, is a drug used in the therapy of certain respiratory diseases. It is approved for use in Russia for the therapy of chronic and acute inflammatory diseases of ENT organs and the respiratory tract (like sinusitis, tracheobronchitis, otitis, laryngitis, and rhinopharyngitis), and for maintenance therapy of asthma.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
1
Compound Sets
18
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMatrix
Enamine BioReference Compounds
LOPAC library
MedChem Express Bioactive Compound Library
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
45
Molecular Weight
260.15
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
1
Rotatable Bonds
3
Ring Count
3
Aromatic Ring Count
1
cLogP
1.8
TPSA
41.57
Fraction CSP3
0.53
Chiral centers
0.0
Largest ring
6.0
QED
0.9
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
alpha
Pathway
GPCR/G protein
Immunology/Inflammation
Metabolism
Neuroscience
Metabolic Enzyme/Protease
Neuronal Signaling
Indication
asthma, otitis, sinusitis, rhinopharyngitis, laryngitis
Disease Area
pulmonary, otolaryngology
MOA
bronchodilator
ATC
R03BX01
R03DX03
Toxicity type
NULL
Target
Histamine Receptor
Phosphodiesterase (PDE)
PDE
Adrenergic Receptor
PDE3
PDE4
Source data

